What You'll Do: Join Gartner as a Business Development Executive for Medium Sized Enterprise Technology vendors... with a market-leading product and ample opportunities for accelerated growth. What You'll Need: Sales Experience: 2-4 years...
about you? Minimum of 5 years of commercial experience including product management and/or direct selling; Bachelor's Degree in Business... between Operations, Engineering and Project Management; Executive presence, confidence, communication skills, influence skills...
is responsible to direct project teams supporting New Product Development (NPD) programs and managing the Current Business Portfolio... for the Clinical Chemistry medical device product line. This position is part of the Clinical Chemistry Department located...
(See Quarterly Business Review with RSM for deeper details) Partners with vendor technology representatives for product resell... opportunities Develop and nurture a trusted advisor relationship with key accounts, customer stakeholders, and executive sponsors...
The princess, who is currently undergoing treatment for cancer, could be seen smiling and waving from the Buckingham Palace balcony. Continue Reading »
As the boss of the world’s biggest oil company flew around the world in early June to drum up investor interest in one of the biggest share sales in recent years, he could breathe a sigh of relief. Continue Reading »
Godavari Biorefineries IPO: The proposed initial share-sale is a combination of fresh issue of equity shares worth ₹325 crore and an OFS of 65.27 lakh equity shares by promoters and an investors Continue Reading »
Hyundai Motor India IPO: The upcoming IPO will make it the country's first car maker to go public in over two decades since Maruti Suzuki India's back in 2003. Continue Reading »
Dividend Stocks: Several companies including Bank of India, L&T Finance Ltd, HDFC Life Insurance Company, among others are trading ex-dividend in the coming week. Continue Reading »
Moody's said companies will perform better with earnings growth forecast through 2025-26, which remains 500 basis points higher than consensus. ‘Our 12-month forward BSE Sensex target is 82,000, implying 14 per cent upside.’ Continue Reading »
Morgan Stanley's cautious outlook on chemical stocks persists due to ongoing challenges. Ratings downgrades were issued for Tata Chemicals, Aarti Industries, and SRF. Preference for commodity chemicals highlighted amidst market conditions. Continue Reading »